3 ms·
Basic research is one of the riskiest aspects though. It is much easier to justify internal research on a product where basic research shows that it works and s
by godelski 6y ago
Basic research is one of the riskiest aspects though. It is much easier to justify internal research on a product where basic research shows that it works and suggests it will scale. MUCH harder when it is a moonshot. You'll notice there's a difference in capital between companies that do the former vs the latter.
- refurb 6y agoTrue. Basic research can takes years to yield anything useful. However, basic research is also relatively low cost compared to the cost of say, running a clinical trial. A single phase 3 clinical trial can run into the hundreds of millions of dollars. You can fund a lot of basic research for that kind of money. When I was in grad school, my PI got grants of ~$2M a year and that supported a lab of ~10 researchers.
- godelski 6y ago> When I was in grad school, my PI got grants of ~$2M a year and that supported a lab of ~10 researchers. There's a big pay difference between grad students, industry researchers, and government researchers, with grad students being the lowest on the totem pole. Which should make sense because they are researchers in training. There's many different types of research too.
- refurb 6y agoThat's true, but even if you quadrupled the costs to account for market rate salaries, you're still two orders of magnitude smaller than typical development costs.
- godelski 6y agoI'm not saying Phase III is really expensive, it is. But you're also ignoring the failure rates of Phase I and Phase II. If you only count the success rate of Phase I's that make it to Phase III and beyond then you're ignoring >80% of the basic research cost.